SQA

OCTOBER 18, 2023

The public consultation is open until 31 December 2023 and the topic will be further discussed during a joint HMA/EMA workshop scheduled for 20-21 November 2023. All interested stakeholders are invited to comment on the draft reflection paper and to identify potential opportunities and risks of AI in the field of medicines.

FDA 40

FDA Compliance Licensing World Health 40

SQA

OCTOBER 18, 2023

The public consultation is open until 31 December 2023 and the topic will be further discussed during a joint HMA/EMA workshop scheduled for 20-21 November 2023. All interested stakeholders are invited to comment on the draft reflection paper and to identify potential opportunities and risks of AI in the field of medicines.

FDA 40

FDA Compliance Licensing World Health 40

SQA

OCTOBER 18, 2024

Most synthetic injectable peptides are regulated as prescription drugs in Canada and require a prescription from a licensed healthcare professional. During the workshop, interactive sessions, demonstrations, and displays took place. Some peptides can be produced for use in medications.

FDA 52

FDA Compliance Public Health World Health 52

SQA

OCTOBER 18, 2024

Most synthetic injectable peptides are regulated as prescription drugs in Canada and require a prescription from a licensed healthcare professional. During the workshop, interactive sessions, demonstrations, and displays took place. Some peptides can be produced for use in medications.

FDA 40

FDA Compliance Public Health Governance 40